Cargando…
Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
The current outbreak of COVID-19 (coronavirus) has been identified by World Health Organization (WHO) as a global pandemic. With the emergence of the COVID-19 virus and considering the lack of effective pharmaceutical treatment for it, there is an urgent need to identify safe and effective drugs or...
Autores principales: | Ghaffari, Samad, Roshanravan, Neda, Tutunchi, Helda, Ostadrahimi, Alireza, Pouraghaei, Mahboub, Kafil, Behnam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IMSS. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158763/ https://www.ncbi.nlm.nih.gov/pubmed/32327293 http://dx.doi.org/10.1016/j.arcmed.2020.04.006 |
Ejemplares similares
-
Assessment of boron-containing compounds and oleoylethanolamide supplementation on the recovery trend in patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
por: Tutunchi, Helda, et al.
Publicado: (2020) -
Possible therapeutic effects of boron citrate and oleoylethanolamide supplementation in patients with COVID-19: A pilot randomized, double-blind, clinical trial
por: Akbari, Neda, et al.
Publicado: (2022) -
Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review
por: Roshanravan, Neda, et al.
Publicado: (2020) -
Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial
por: Tutunchi, Helda, et al.
Publicado: (2020) -
A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases
por: Roshanravan, Neda, et al.
Publicado: (2022)